Michael G. Hanna

Research interests

Publications

• Cardiolipin, Mitochondria, and Neurological Disease

  Trends in Endocrinology and Metabolism · 2021 · 10.1016/j.tem.2021.01.006

• AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders

  Nature Communications · 2019 · https://doi.org/10.1038/s41467-019-10910-w

• Review of the Diagnosis and Treatment of Periodic Paralysis

  Muscle & Nerve · 2017 · 10.1002/mus.26009

• The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation

  European Heart Journal · 2016 · https://doi.org/10.1093/eurheartj/ehw054

• MRI biomarker assessment of neuromuscular disease progression: a prospective observational cohort study

  The Lancet Neurology · 2015 · 10.1016/s1474-4422(15)00242-2

• Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial

  European Heart Journal · 2014 · 10.1093/eurheartj/ehu046

• Major Bleeding in Patients With Atrial Fibrillation Receiving Apixaban or Warfarin

  Journal of the American College of Cardiology · 2014 · 10.1016/j.jacc.2014.02.549

• Polymyositis, Dermatomyositis, and Inclusion Body Myositis

  UCL Discovery (University College London) · 2013

• The UK MRC Mitochondrial Disease Patient Cohort Study: clinical phenotypes associated with the m.3243A>G mutation--implications for diagnosis and management

  Journal of Neurology Neurosurgery & Psychiatry · 2013 · 10.1136/jnnp-2012-303528

• N-Terminal Pro–B-Type Natriuretic Peptide for Risk Assessment in Patients With Atrial Fibrillation

  Journal of the American College of Cardiology · 2013 · 10.1016/j.jacc.2012.11.082

• Mutations in the Gene PRRT2 Cause Paroxysmal Kinesigenic Dyskinesia with Infantile Convulsions

  Cell Reports · 2012 · 10.1016/j.celrep.2011.11.001

• Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial

  The Lancet Neurology · 2012 · 10.1016/s1474-4422(12)70092-3

• Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial

  European Heart Journal · 2012 · https://doi.org/10.1093/eurheartj/ehs274

• Apixaban versus Warfarin in Patients with Atrial Fibrillation

  New England Journal of Medicine · 2011 · https://doi.org/10.1056/nejmoa1107039

• Primary episodic ataxias: diagnosis, pathogenesis and treatment

  Brain · 2007 · 10.1093/brain/awm126

• The primary periodic paralyses: diagnosis, pathogenesis and treatment

  Brain · 2005 · 10.1093/brain/awh639

• International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease

  Lara D. Veeken · 2003 · 10.1093/rheumatology/keg427

• Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel

  The Lancet · 2001 · 10.1016/s0140-6736(01)05971-2

• Clinical, genetic, and expression studies of mutations in the potassium channel gene KCNA1 reveal new phenotypic variability

  Annals of Neurology · 2000 · 10.1002/1531-8249(200010)48:4<647::aid-ana12>3.0.co;2-q

• Adjuvant Active Specific Immunotherapy for Stage II and III Colon Cancer With an Autologous Tumor Cell Vaccine: Eastern Cooperative Oncology Group Study E5283

  Journal of Clinical Oncology · 2000 · 10.1200/jco.2000.18.1.148

• Exercise Intolerance Due to Mutations in the CytochromebGene of Mitochondrial DNA

  New England Journal of Medicine · 1999 · 10.1056/nejm199909303411404

• Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial

  The Lancet · 1999 · https://doi.org/10.1016/s0140-6736(98)07186-4

• Adjuvant active specific immunotherapy for human colorectal cancer: 6.5-year median follow-up of a phase III prospectively randomized trial.

  Journal of Clinical Oncology · 1993 · 10.1200/jco.1993.11.3.390

• Immunotherapy of Cancer: Regression of Intradermal Tumors and Prevention of Growth of Lymph Node Metastases After Intralesional Injection of Living Mycobacterium bovis

  JNCI Journal of the National Cancer Institute · 1972 · 10.1093/jnci/49.1.119

• Effects of preezing on marrow stem cell suspensions: Interactions of cooling and warming rates in the presence of pvp, sucrose, or glycerol

  Cryobiology · 1970 · 10.1016/s0011-2240(70)80086-4

Current projects

No projects listed.